Javascript must be enabled to continue!
Acetylcysteine and fulminant hepatic failure
View through CrossRef
Background.
When administered early after an overdose of acetaminophen, intravenous acetylcysteine prevents hepatic necrosis by replenishing reduced stores of glutathione. How acetylcysteine improves the survival of patients with established liver damage induced by acetaminophen, however, is unknown. This study was undertaken to determine whether the beneficial effect of acetylcysteine under such circumstances could be due to enhancement of oxygen delivery and consumption.
Methods.
We studied the effect of acetylcysteine on systemic hemodynamics and oxygen transport in 12 patients with acetaminophen-induced fulminant hepatic failure and 8 patients with acute liver failure from other causes. The acetylcysteine was given in a dose of 150 mg per kilogram of body weight in 250 ml of 5 percent dextrose over a period of 15 minutes and then in a dose of 50 mg per kilogram in 500 ml of 5 percent dextrose over a period of 4 hours; measurements were made before treatment began and after 30 minutes of the regimen.
Results.
In the patients with acetaminophen-induced liver failure, the infusion of acetylcysteine resulted in an increase in mean oxygen delivery from 856 to 975 ml per minute per square meter of body-surface area (P = 0.0036), due to an increase in the cardiac index from 5.6 to 6.7 liters per minute per square meter (P = 0.0021). Mean arterial pressure rose from 88 to 95 mm Hg (P = 0.0054) despite a decrease in systemic vascular resistance from 1296 to 1113 dyn · sec · cm−6 per square meter (P = 0.027). There was an increase in oxygen consumption from 127 to 184 ml per minute per square meter (P = 0.0007) associated with an increase in the oxygen-extraction ratio from 16 to 21 percent (P = 0.022). The effects in the patients with acute liver failure from other causes were similar.
Conclusions.
The increase in oxygen delivery and consumption in response to acetylcysteine may account for its beneficial effect on survival in patients with fulminant hepatic failure induced by acetaminophen.
Ovid Technologies (Wolters Kluwer Health)
Title: Acetylcysteine and fulminant hepatic failure
Description:
Background.
When administered early after an overdose of acetaminophen, intravenous acetylcysteine prevents hepatic necrosis by replenishing reduced stores of glutathione.
How acetylcysteine improves the survival of patients with established liver damage induced by acetaminophen, however, is unknown.
This study was undertaken to determine whether the beneficial effect of acetylcysteine under such circumstances could be due to enhancement of oxygen delivery and consumption.
Methods.
We studied the effect of acetylcysteine on systemic hemodynamics and oxygen transport in 12 patients with acetaminophen-induced fulminant hepatic failure and 8 patients with acute liver failure from other causes.
The acetylcysteine was given in a dose of 150 mg per kilogram of body weight in 250 ml of 5 percent dextrose over a period of 15 minutes and then in a dose of 50 mg per kilogram in 500 ml of 5 percent dextrose over a period of 4 hours; measurements were made before treatment began and after 30 minutes of the regimen.
Results.
In the patients with acetaminophen-induced liver failure, the infusion of acetylcysteine resulted in an increase in mean oxygen delivery from 856 to 975 ml per minute per square meter of body-surface area (P = 0.
0036), due to an increase in the cardiac index from 5.
6 to 6.
7 liters per minute per square meter (P = 0.
0021).
Mean arterial pressure rose from 88 to 95 mm Hg (P = 0.
0054) despite a decrease in systemic vascular resistance from 1296 to 1113 dyn · sec · cm−6 per square meter (P = 0.
027).
There was an increase in oxygen consumption from 127 to 184 ml per minute per square meter (P = 0.
0007) associated with an increase in the oxygen-extraction ratio from 16 to 21 percent (P = 0.
022).
The effects in the patients with acute liver failure from other causes were similar.
Conclusions.
The increase in oxygen delivery and consumption in response to acetylcysteine may account for its beneficial effect on survival in patients with fulminant hepatic failure induced by acetaminophen.
Related Results
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Management of childhood esophageal varices: learnings from an advanced medical centre
Management of childhood esophageal varices: learnings from an advanced medical centre
Background: Variceal bleeding represents a significant clinical emergency with potential life-threatening implications in infants and children. Endoscopic band ligation is the stan...
Human hepatic regenerative stimulator substance: Partial purification and biological characterization of hepatic stimulator substance from human fetal liver cells
Human hepatic regenerative stimulator substance: Partial purification and biological characterization of hepatic stimulator substance from human fetal liver cells
Current support or replacement therapies for fulminant acute hepatic failure are frequently very disappointing. In this study, human hepatic stimulator substance—a liver-specific g...
Differential effects of systemic immune inflammation indices on hepatic steatosis and hepatic fibrosis: evidence from NHANES 1999-2018
Differential effects of systemic immune inflammation indices on hepatic steatosis and hepatic fibrosis: evidence from NHANES 1999-2018
Abstract
Background
Several studies have demonstrated that systemic immune inflammation index (SII) has a positive relationship with hepatic steatosis. However, it is lack...
Nimesulide associated fulminant hepatic failure
Nimesulide associated fulminant hepatic failure
AbstractPurposeIt is controversial whether the non‐steroidal inflammatory drug nimesulide is associated with severe hepatotoxicity. Our objective was to determine whether nimesulid...
Hepatitis E associated fulminant hepatic failure and its outcome in pregnancy.
Hepatitis E associated fulminant hepatic failure and its outcome in pregnancy.
Objectives: To determine the clinical features and outcome of hepatitis E associated fulminant hepatic failure in pregnancy. Study Design: Observational Retrospective study. Settin...
Hepatoprotective role of tecomella undulata bark extract in comparison with n- acetylcysteine on acetaminophen induced hepatotoxicity in albino rats.
Hepatoprotective role of tecomella undulata bark extract in comparison with n- acetylcysteine on acetaminophen induced hepatotoxicity in albino rats.
Objective: To assess hepatoprotective effect of Tecomella Undulata bark extract on acetaminophen induced hepatotoxicity in albino rats as compared to N-Acetylcysteine. Study Design...
Powdered Sorbent Liver Dialysis and Pheresis in Treatment of Hepatic Failure
Powdered Sorbent Liver Dialysis and Pheresis in Treatment of Hepatic Failure
Abstract: The Liver Dialysis Unit (the Unit) is a liver‐assist device that employs hemodiabsorption (dialysis of blood against powdered sorbents) to selectively remove numerous sma...

